Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ENTA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ENTA investment potential.

What is ENTA stock price today?

Get real-time ENTA stock price, historical data, and price charts on Financhill. Track ENTA performance with our advanced analysis tools.

Is ENTA a good investment?

Evaluate ENTA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ENTA stock?

To buy ENTA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ENTA?

View detailed market capitalization data and company valuation metrics for ENTA on our comprehensive analysis page.

What is the P/E ratio of ENTA?

Use our fundamental analysis tools to view ENTA P/E ratio and compare valuation metrics with industry peers.

What are ENTA earnings?

View ENTA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Enanta Pharmaceuticals, Inc. Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

ENTA
Enanta Pharmaceuticals, Inc.

Last Price:

$14.09

Seasonality Move:

1.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Enanta Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Enanta Pharmaceuticals, Inc. has on average historically risen by 6% based on the past 12 years of stock performance.
Enanta Pharmaceuticals, Inc. has risen higher in 5 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.67%
Is Enanta Pharmaceuticals, Inc. Stock Undervalued?

The current Enanta Pharmaceuticals, Inc. [ENTA] share price is $14.09. The Score for ENTA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
ENTA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Enanta Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Enanta Pharmaceuticals, Inc. has on average historically risen by 6% based on the past 12 years of stock performance.

Enanta Pharmaceuticals, Inc. Stock Rating

Sell

Enanta Pharmaceuticals, Inc. (ENTA) is a Sell

Is Enanta Pharmaceuticals, Inc. overpriced?

Enanta Pharmaceuticals, Inc. has risen higher in 5 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.67%

Enanta Pharmaceuticals, Inc. Stock Price History

Is ENTA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

enanta.com

52-Week Data

52-Week High:

15.34

52-Week Low:

4.09

Prediction Charts

Market Cap:

406.7M

Price in USD:

14.09

Volume:

246.1K

Beta:

0.69

Technical Analysis

SMA50:

11.63

SMA100:

9.77

SMA200:

8.09

52-Wk Change:

65.18%

Stock Predictions

Is Enanta Pharmaceuticals, Inc. stock public?

Yes, Enanta Pharmaceuticals, Inc. is a publicly traded company.
What is the Enanta Pharmaceuticals, Inc. stock quote today?

The Enanta Pharmaceuticals, Inc. stock price is 14.09 USD today.
How to buy Enanta Pharmaceuticals, Inc. stock online?

You can buy Enanta Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	11.98	12.06	12.50	11.70
Nov-17	12.06	12.82	12.94	11.85
Nov-18	12.22	12.36	13.55	11.80
Nov-19	12.27	12.13	12.81	11.89
Nov-20	12.29	12.13	12.84	11.98
Nov-21	12.08	12.73	13.00	11.89
Nov-24	12.91	13.65	13.78	12.70
Nov-25	13.78	13.66	13.86	12.97
Nov-26	13.72	13.94	14.21	13.50
Nov-28	13.97	14.12	14.22	13.63
Dec-1	13.80	14.14	14.51	13.80
Dec-2	14.08	13.96	14.32	13.80
Dec-3	14.02	14.24	14.52	14.00
Dec-4	14.00	14.09	14.46	13.93

Enanta Pharmaceuticals, Inc. Earnings

Enanta Pharmaceuticals, Inc. Earnings Report: Per Share Enanta Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Enanta Pharmaceuticals, Inc. Forecast Revenue Growth

Enanta Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Enanta Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.47 per share.

* Enanta Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.